HealthcareFDA accepts SpringWorks' application for mirdametinib for NF1-PNBy Helitra.com·August 29, 2024·1 min read FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: SeekingalphaADVERTISEMENT ADVERTISEMENTaccepts application FDA mirdametinib NF1PN SpringWorks039 Post navigation Previous storyPfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapiesNext storyKrystal Biotech's Jeune reports promising phase 1 data on wrinkles drug
Fitness · HealthcareShemar Moore Opens Up About His 3-Surgery Journey To Fix His BunionsNovember 4, 2026Even at the peak of his modeling career, Shemar Moore was wrestling with a vulnerability he kept strictly out of frame. The 56-year-old…
Fitness · Healthcare4 Dermatologists Explain Why Bar Soap Isn’t Bad for Your SkinNovember 4, 2026In the age of TikTok, multi-step skincare routines are more ubiquitous than ever. And if you’re anything like me, you’ve watched more facial…
Fitness · HealthcareMorning Sickness During Pregnancy: How to Cope and How Partners Can HelpNovember 4, 2026Morning sickness is one of the most familiar challenges of early pregnancy, but the experience can be exhausting for expectant mothers. Despite its…